Clinical Trial

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

Study acronym: STAR
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Multicenter, parallel-group, randomized clinical trial comparing the administration of systemic corticosteroids at a dose equivalent to 40 mg of prednisolone per day for 7 days vs no corticosteroid administration among adults hospitalized with severe acute respiratory infection and hypoxemia.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-22; most recent amendment 2026-02-17.
Trial Details
NCT Number NCT07199192
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: National Institutes of Health (NIH), University of Minnesota
Conditions Hypoxemia, Severe Acute Respiratory Syndrome
Enrollment 3,000 participants
Start Date 2026-03-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19